Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodeling

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 50, 2012, Pages 20596-20601

  Rajagopalan, Sumati ^a   Long, Eric O ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

KIR2DL4; Microarray

Indexed keywords

HETEROCHROMATIN PROTEIN 1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL4; PROTEIN P21; TRANSCRIPTOME; CBX3 PROTEIN, HUMAN; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; HLA G ANTIGEN; KIR2DL4 PROTEIN, HUMAN; NONHISTONE PROTEIN;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL AGING; CELL SHAPE; CELL SIZE; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE RESPONSE; GROWTH DISORDER; HETEROCHROMATIN; HUMAN; HUMAN CELL; NATURAL KILLER CELL; NORMAL HUMAN; NUCLEAR REPROGRAMMING; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SENESCENCE; SIGNAL TRANSDUCTION; TISSUE REPAIR; VASCULAR ENDOTHELIAL CELL; VASCULAR REMODELING; BLOOD VESSEL; CAPILLARY PERMEABILITY; CELL CULTURE; CYTOLOGY; DNA DAMAGE; DRUG POTENTIATION; FEMALE; FETOMATERNAL TRANSFUSION; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PREGNANCY;

BLOOD VESSELS; CAPILLARY PERMEABILITY; CELL AGING; CELLS, CULTURED; CHROMOSOMAL PROTEINS, NON-HISTONE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; FEMALE; HLA-G ANTIGENS; HUMANS; KILLER CELLS, NATURAL; MATERNAL-FETAL EXCHANGE; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHORYLATION; PREGNANCY; RECEPTORS, KIR2DL4; SIGNAL TRANSDUCTION;

EID: 84874405465     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1208248109     Document Type: Article

References (36)

1. Moffett-King A (2002) Natural killer cells and pregnancy. Nat Rev Immunol 2(9):656–663.
2. Bilinski MJ, et al. (2008) Uterine NK cells in murine pregnancy. Reprod Biomed Online 16(2):218–226.
3. Hanna J, et al. (2006) Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 12(9):1065–1074.
4. Hiby SE, et al. (2010) Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J Clin Invest 120(11):4102–4110.
5. Parham P, Guethlein LA (2010) Pregnancy immunogenetics: NK cell education in the womb? J Clin Invest 120(11):3801–3804.
6. Hiby SE, et al. (2004) Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 200(8):957–965.
7. Rajagopalan S, et al. (2006) Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol 4(1):e9.
8. Rajagopalan S (2010) Endosomal signaling and a novel pathway defined by the natural killer receptor KIR2DL4 (CD158d). Traffic 11(11):1381–1390.
9. Parham P (2005) MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 5(3):201–214.
10. Long EO (2008) Negative signaling by inhibitory receptors: the NK cell paradigm. Immunol Rev 224:70–84.
11. Rajagopalan S, Moyle MW, Joosten I, Long EO (2010) DNA-PKcs controls an endosomal signaling pathway for a proinflammatory response by natural killer cells. Sci Signal 3(110):ra14.
12. Abraham RT (2004) PI 3-kinase related kinases: ‘Big’ players in stress-induced signaling pathways. DNA Repair (Amst) 3(8-9):883–887.
13. Bozulic L, Surucu B, Hynx D, Hemmings BA (2008) PKBalpha/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival. Mol Cell 30 (2):203–213.
14. d’Adda di Fagagna F (2008) Living on a break: Cellular senescence as a DNA-damage response. Nat Rev Cancer 8(7):512–522.
15. Zhang R, Adams PD (2007) Heterochromatin and its relationship to cell senescence and cancer therapy. Cell Cycle 6(7):784–789.
16. Zhang R, Chen W, Adams PD (2007) Molecular dissection of formation of senescence-associated heterochromatin foci. Mol Cell Biol 27(6):2343–2358.
17. Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O (2009) Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc 4(12):1798–1806.
18. Coppé JP, et al. (2011) Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype. J Biol Chem 286(42):36396–36403.
19. Campisi J, d’Adda di Fagagna F (2007) Cellular senescence: When bad things happen to good cells. Nat Rev Mol Cell Biol 8(9):729–740.
20. Rodier F, Campisi J (2011) Four faces of cellular senescence. J Cell Biol 192(4):547–556.
21. Mason DX, Jackson TJ, Lin AW (2004) Molecular signature of oncogenic ras-induced senescence. Oncogene 23(57):9238–9246.
22. Kuilman T, et al. (2008) Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133(6):1019–1031.
23. Acosta JC, et al. (2008) Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133(6):1006–1018.
24. Coppé JP, et al. (2008) Senescence-associated secretory phenotypes reveal cell-non-autonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 6 (12):2853–2868.
25. Krizhanovsky V, et al. (2008) Senescence of activated stellate cells limits liver fibrosis. Cell 134(4):657–667.
26. Jun JI, Lau LF (2010) The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol 12(7):676–685.
27. Kuilman T, Peeper DS (2009) Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer 9(2):81–94.
28. Li C, Houser BL, Nicotra ML, Strominger JL (2009) HLA-G homodimer-induced cytokine secretion through HLA-G receptors on human decidual macrophages and natural killer cells. Proc Natl Acad Sci USA 106(14):5767–5772.
29. Baker DJ, et al. (2011) Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479(7372):232–236.
30. Koopman LA, et al. (2003) Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 198(8):1201–1212.
31. Rizzo R, Vercammen M, van de Velde H, Horn PA, Rebmann V (2011) The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells. Cell Mol Life Sci 68(3):341–352.
32. Menier C, et al. (2010) Recent advances on the non-classical major histocompatibility complex class I HLA-G molecule. Tissue Antigens 75(3):201–206.
33. Fujii T, Ishitani A, Geraghty DE (1994) A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol 153(12):5516–5524.
34. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society 57(1):289–300.
35. Subramanian A, et al. (2005) Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102(43):15545–15550.
36. Mootha VK, et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34(3):267–273.